REPLIVEL Trademark

Trademark Overview

On Friday, December 22, 2006, a trademark application was filed for REPLIVEL with the United States Patent and Trademark Office. The USPTO has given the REPLIVEL trademark a serial number of 77070805. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, January 27, 2017. This trademark is owned by Sunesis Pharmaceuticals, Inc.. The REPLIVEL trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the treatment of tumors and cancer
replivel

General Information

Serial Number77070805
Word MarkREPLIVEL
Filing DateFriday, December 22, 2006
Status710 - CANCELLED - SECTION 8
Status DateFriday, January 27, 2017
Registration Number3807429
Registration DateTuesday, June 22, 2010
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 24, 2007

Trademark Statements

Goods and Servicespharmaceutical preparations for the treatment of tumors and cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, January 27, 2017
Primary Code005
First Use Anywhere DateMonday, March 15, 2010
First Use In Commerce DateMonday, March 15, 2010

Trademark Owner History

Party NameSunesis Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameSunesis Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameSunesis Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Friday, January 27, 2017CANCELLED SEC. 8 (6-YR)
Tuesday, June 22, 2010REGISTERED-PRINCIPAL REGISTER
Thursday, May 20, 2010NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, May 19, 2010LAW OFFICE REGISTRATION REVIEW COMPLETED
Wednesday, May 19, 2010ASSIGNED TO LIE
Tuesday, May 11, 2010ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, April 20, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 19, 2010STATEMENT OF USE PROCESSING COMPLETE
Friday, April 16, 2010USE AMENDMENT FILED
Monday, April 19, 2010EXTENSION 5 GRANTED
Friday, April 16, 2010EXTENSION 5 FILED
Friday, April 16, 2010TEAS EXTENSION RECEIVED
Friday, April 16, 2010TEAS STATEMENT OF USE RECEIVED
Monday, October 19, 2009EXTENSION 4 GRANTED
Friday, October 16, 2009EXTENSION 4 FILED
Friday, October 16, 2009TEAS EXTENSION RECEIVED
Tuesday, May 5, 2009EXTENSION 3 GRANTED
Thursday, April 16, 2009EXTENSION 3 FILED
Tuesday, May 5, 2009CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, April 16, 2009TEAS EXTENSION RECEIVED
Tuesday, October 14, 2008EXTENSION 2 GRANTED
Tuesday, October 14, 2008EXTENSION 2 FILED
Tuesday, October 14, 2008TEAS EXTENSION RECEIVED
Wednesday, October 8, 2008TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 15, 2008APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, July 15, 2008TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, April 16, 2008EXTENSION 1 GRANTED
Wednesday, April 16, 2008EXTENSION 1 FILED
Wednesday, April 16, 2008TEAS EXTENSION RECEIVED
Tuesday, October 16, 2007NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 24, 2007PUBLISHED FOR OPPOSITION
Wednesday, July 4, 2007NOTICE OF PUBLICATION
Monday, May 7, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, May 7, 2007ASSIGNED TO LIE
Tuesday, April 17, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 17, 2007ASSIGNED TO EXAMINER
Thursday, December 28, 2006NEW APPLICATION ENTERED IN TRAM

Related Keywords

replivel cancer tumors treatment preparations pharmaceutical